Suppr超能文献

1型血管紧张素II受体跨膜结构域中的极性残基是结合和偶联所必需的。通过共表达两个缺陷突变体重建结合位点。

Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.

作者信息

Monnot C, Bihoreau C, Conchon S, Curnow K M, Corvol P, Clauser E

机构信息

INSERM, Unité 36, College de France, Paris, France.

出版信息

J Biol Chem. 1996 Jan 19;271(3):1507-13. doi: 10.1074/jbc.271.3.1507.

Abstract

Type 1 angiotensin receptors (AT1) are G-protein coupled receptors, mediating the physiological actions of the vasoactive peptide angiotensin II. In this study, the roles of 7 amino acids of the rat AT1A receptor in ligand binding and signaling were investigated by performing functional assays of individual receptor mutants expressed in COS and Chinese hamster ovary cells. Substitutions of polar residues in the third transmembrane domain with Ala indicate that Ser105, Ser107, and Ser109 are not essential for maintenance of the angiotensin II binding site. Replacement of Asn111 or Ser115 does not alter the binding affinity for peptidic analogs, but modifies the ability of the receptor to interact with AT1 (DuP753)- or AT2 (CGP42112A)-specific ligands. These 2 residues are probably involved in determining the binding specificity for these analogs. The absence of G-protein coupling to the Ser115 mutant suggests that this residue, in addition to previously identified residues, Asp74 and Tyr292, participates in the receptor activation mechanism. Finally, Lys102 (third helix) and Lys199 (fifth helix) mutants do not bind angiotensin II or different analogs. Co-expression of these two deficient receptors permitted the restoration of a normal binding site. This effect was not due to homologous recombination of the cDNAs but to protein trans-complementation.

摘要

1型血管紧张素受体(AT1)是G蛋白偶联受体,介导血管活性肽血管紧张素II的生理作用。在本研究中,通过对在COS细胞和中国仓鼠卵巢细胞中表达的单个受体突变体进行功能测定,研究了大鼠AT1A受体的7个氨基酸在配体结合和信号传导中的作用。用丙氨酸取代第三个跨膜结构域中的极性残基表明,Ser105、Ser107和Ser109对于维持血管紧张素II结合位点不是必需的。替换Asn111或Ser115不会改变对肽类似物的结合亲和力,但会改变受体与AT1(DuP753)或AT2(CGP42112A)特异性配体相互作用的能力。这两个残基可能参与确定这些类似物的结合特异性。Ser115突变体缺乏与G蛋白的偶联表明,除了先前确定的残基Asp74和Tyr292外,该残基也参与受体激活机制。最后,Lys102(第三螺旋)和Lys199(第五螺旋)突变体不结合血管紧张素II或不同的类似物。这两种缺陷受体的共表达使正常结合位点得以恢复。这种效应不是由于cDNA的同源重组,而是由于蛋白质反式互补。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验